Literature DB >> 12207347

A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells.

Pauline Soulas1, Severine Koenig-Marrony, Sylvie Julien, Anne-Marie Knapp, Jean-Claude Garaud, Jean-Louis Pasquali, Thierry Martin.   

Abstract

Under non-autoimmune conditions, rheumatoid factor (RF) B cells coexist peacefully with their antigen (IgG), or can be transiently activated during secondary immune responses because they can present xenoantigens to specific T cells captured in immune complex form. Such a situation should lead to affinity maturation of RF B cells and potentially dangerous production of high-affinity RF. We used two lines of transgenic mice expressing a somatically mutated pathological human RF in presence (IgM and IgD) or in absence (IgM only) of surface IgD, and confirm that RF B cell tolerance can result from an antigen-induced specific, but incomplete, deletion of naive RF B cells after antigen encounter. This deletion mainly concerns immature, transitional B cells. On the contrary, mature, IgM- and IgD-expressing RF B cells are resistant to such a deletion. These IgM and IgD RF B cells are functional and activable through both B cell receptor dependent (anti-IgM) and independent (LPS) pathways, but they are not fully responsive to human IgG either in vivo or in vitro. Taken together, these results suggest that another mechanism could be involved in the silencing of mature naive IgM and IgD RF B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207347     DOI: 10.1002/1521-4141(200209)32:9<2623::AID-IMMU2623>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  The riddle of the dual expression of IgM and IgD.

Authors:  Roland Geisberger; Marinus Lamers; Gernot Achatz
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

2.  Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection.

Authors:  Pauline Soulas; Anne Woods; Benoit Jaulhac; Anne-Marie Knapp; Jean-Louis Pasquali; Thierry Martin; Anne-Sophie Korganow
Journal:  J Clin Invest       Date:  2005-07-21       Impact factor: 14.808

Review 3.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

4.  The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoantibodies and exacerbates glomerulonephritis in murine lupus.

Authors:  L Guo; J Tian; Z Guo; B Zheng; S Han
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

Review 5.  What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis?

Authors:  Roberta Reis Soares; Luciana Maria Ribeiro Antinarelli; Clarice Abramo; Gilson Costa Macedo; Elaine Soares Coimbra; Kézia Katiani Gorza Scopel
Journal:  Pathog Glob Health       Date:  2017-03-29       Impact factor: 2.894

6.  Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance.

Authors:  Anne Woods; Fanny Monneaux; Pauline Soulas-Sprauel; Sylviane Muller; Thierry Martin; Anne-Sophie Korganow; Jean-Louis Pasquali
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

7.  IgM, IgG, and IgA rheumatoid factors in pigeon hypersensitivity pneumonitis.

Authors:  Mariana Tellez Araiza; Diana E Aguilar León; Virginia Novelo Retana; Erasmo Martínez-Cordero
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

8.  IgD attenuates the IgM-induced anergy response in transitional and mature B cells.

Authors:  Zahra Sabouri; Samuel Perotti; Emily Spierings; Peter Humburg; Mehmet Yabas; Hannes Bergmann; Keisuke Horikawa; Carla Roots; Samantha Lambe; Clara Young; T Dan Andrews; Matthew Field; Anselm Enders; Joanne H Reed; Christopher C Goodnow
Journal:  Nat Commun       Date:  2016-11-10       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.